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Abstract
BACKGROUND/OBJECTIVES—To evaluate how receipt and timing of nursing home (NH) 
palliative care consults (primarily by nurse practitioners with palliative care expertise) is 
associated with end-of-life care transitions and acute care use
DESIGN—A propensity-score (pscore) matched retrospective cohort study
SETTING—Forty-six NHs in two states
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PARTICIPANTS—NH residents who died in 2006–2010 stratified by days between initial consult 
and death: ≤7, 8–30, 31–60 or 61–180. By strata, pscore matching identified three controls 
(n=1,174) for each consult recipient (n=477).
MEASUREMENTS—Outcomes were hospitalizations in the last 7, 30 and 60 days of life, 
emergency room visits in the last 30 and 60 days, and any potentially burdensome care transition 
defined as hospitalization or hospice admission within three days of death or two or more 
hospitalizations or emergency room visits within 30. Weighted multivariate logistic regression 
analyses evaluated outcomes.
RESULTS—Residents with consults (compared to controls) had lower rates of hospitalization, 
with rates lowest when initial consults were furthest from death. For instance, among residents 
with initial consults 8–30 days before death the adjusted hospitalization rate in the last seven days 
of life was 11.1% (95% CI, 9.79 to 12.43) compared to 22.0% (95% CI, 20.62 to 23.41) among 
controls; however, among those with initial consults 61–180 days before death, rates were 6.9% 
(95% CI, 5.47 to 8.37) compared to 22.9% (95% CI, 20.48 to 25.42). Potentially burdensome 
transition rates were lower when consults were 61–180 days before death (16.2% (95% CI, 13.74 
to 18.57) compared to 28.2% (95% CI, 25.82 to 30.59)) for controls.
CONCLUSION—Findings suggest palliative care consults improve end-of-life NH care by 
reducing acute care use and potentially burdensome care transitions.
Keywords
palliative care; nursing homes; Medicare
INTRODUCTION
Palliative care (PC) optimizes quality of life for persons with serious illness by anticipating, 
preventing, and alleviating suffering across the care continuum.1 The Institute of Medicine 
recommends persons with advanced serious illness should have access to specialty palliative 
care across care settings.2 Still, for the half million older adults dying in United States (US) 
nursing homes (NH) each year, as well as those living in NHs with advanced illness, access 
to palliative care is often lacking.3–6 Hospice is a major source of palliative care in NHs but 
half of NH hospice patients have enrollments of 22 days or less and long hospice stays for 
this population are costly and trigger regulatory scrutiny.7–9 An alternative model is needed 
to expand the availability of palliative care expertise in NHs beyond that currently available 
through Medicare hospice.3,5,6,10 To expand access, some NHs now offer palliative care 
consults by external providers with palliative care expertise (i.e., specialty palliative care 
consults) to residents; however, empirical evidence of the value of this approach is absent.
Palliative care consults differ from Medicare hospice in that they do not require active choice 
by residents/families or forfeiture of Medicare Part-A benefits (i.e., hospital and skilled 
nursing facility care). Also, a physician-certified terminal prognosis of six months or less is 
not required. Similar to NH hospice, palliative care consults are often initiated at the request 
of NH staff or family members3,11 and must be ordered by attending physicians. Staff and 
family requests often result from a recognized need such as symptom management or 
assistance with difficult treatment decisions. They also arise when hospice is not feasible 
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due to receipt of Medicare skilled nursing facility (SNF) care or a life expectancy greater 
than six months. Unlike hospice, there is no designated Medicare payment stream for 
palliative care consults; they are billed as NH visits under Medicare Part B.
In hospitals, palliative care consults are consistently associated with lower intensity of 
treatments and costs, and in outpatient settings, with improved quality of life and reductions 
in aggressive care.12–16 Additionally, earlier (compared to later) hospice or palliative care 
enrollment is associated with greater reductions in acute care use and improvements in 
quality.13,15,17–19
No study has examined how specialty palliative consults affect health care utilization for 
residents in NHs and whether earlier receipt may be more effective. Therefore, in this study, 
we examined how consults in NHs are associated with the use of acute care service and 
burdensome transitions14 near the end-of-life. Also, although not a main outcome, we 
examined Medicare expenditures near the end-of-life to understand how observed benefits 
are associated with Medicare costs.
METHODS
Study Data and Population
Given there was no Medicare Part B payment code(s) to validly identify palliative care 
consults in the time period studied, we collaborated with two palliative care provider 
organizations to identify NH consult recipients. Both are long-standing providers of NH 
consults and are subsidiaries of hospices located in hospice certificate-of-need states (North 
Carolina and Rhode Island); during study years, they were the exclusive providers of 
palliative care consults in the two counties in North Carolina and the six in Rhode Island 
where study NHs were located. After obtaining a data use agreement (DUA) from the 
Centers for Medicare and Medicaid Services (CMS) and Health Insurance Portability and 
Accountability Act (HIPAA) waiver approvals, the two organizations shared NH consult 
data for years 2005–2010. Data shared included a consult recipient’s date of birth, Medicare 
(or insurance) identification (ID) number, gender, dates of initial palliative consults and NH 
identifying information. This study was approved by Brown University’s Institutional 
Review Board.
Provider data were linked to Medicare enrollment and Part A claims data, and NH resident 
assessment Minimum Data Set (MDS) data. The MDS is mandated for all Medicare or 
Medicaid certified NHs and includes comprehensive demographic and clinical data. The 
enrollment file contains data on Medicare eligibility, Medicare Advantage enrollment and 
date of death. Part A claims data provide information on hospital, skilled nursing facility 
(SNF), emergency room (ER), home health care and hospice use. Data from the Online 
Survey, Certification, and Reporting (OSCAR) database provided information on NH 
characteristics.
We identified NH decedents in 2006–10 with initial palliative care consults within 180 days 
of death, who were Medicare-eligible and not enrolled in Medicare Advantage in the last 
year of life (given claims data are not available for Medicare Advantage enrollees; n=653). 
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For each resident, we identified a baseline MDS dated prior to the initial palliative care 
consult, but by no more than 180 days. We removed two residents with a hospice discharge 
on the date of first consult, ten with consults on the date of death and 133 with no MDS data 
in the required time window. Ninety percent of the 145 residents removed versus 45% of 
those remaining had short NH stays (i.e., <90 days). The resulting palliative care consult 
sample consisted of 508 residents (77.8%) from 46 of the 53 NHs (86.8%). Although 
examination of consult after 2010 would have been desirable, the MDS changed in October 
of 2010. The newer MDS is not comparable to the earlier version and is missing key 
information, in particular, variables indicating preference (i.e., the presence of do not 
resuscitate (DNR) and do not hospitalize (DNH) orders).
To control for potential differences and preferences of NH residents with and without 
palliative care consults, we chose propensity-score (pscore) matched controls. Decedents 
eligible to serve as controls came from the same NHs and time frames, and were also 
Medicare-eligible with no Medicare Advantage in the last year of life. They also had to have 
MDS assessments in time periods comparable to consult decedents’ baseline assessments. 
To enable examination of the timing of palliative care, and congruent with previous similar 
research13,15,16,18,19, we first stratified the treatment sample into four treatment groups by 
days between the initial consult and death: ≤ 7, 8–30, 31–60 and 61–180. Variables for 
pscore model inclusion were identified through previous related research.7,18,20–23 Using 
pscore matching with replacement, we identified three matched controls for 477 of the 508 
consult decedents (93.9%) for a total of 1,174 propensity-matched controls. (See also On-
line Supplemental Material for additional information on pscore matching.)
Variables of Interest
Independent Variable – Palliative care consult and its timing—The treatment of 
interest was initial exposure to any specialty palliative care consult in the last six months of 
life, and to examine timing (as discussed above), treatment groups were created using the 
days between the initial consult and death: ≤ 7, 8–30, 31–60 and 61–180. At both study 
sites, a palliative care consult visit primarily consists of care by nurse practitioners, under 
the supervision of certified palliative care physicians. These nurse practitioners specialize in 
palliative care (do not provide primary care) and have extensive palliative care training. At 
initial visits and at both sites, nurse practitioners typically review diagnoses and prognoses 
and address symptom control needs. To ensure treatment consistent with preferences, they 
also review advance directives, if available, and discuss goals of care. Family meetings are a 
key component of many consults. While interdisciplinary palliative care team members may 
visit residents when needs exist, such visits are not routine or integral to the care model. 
Similar to other studies,12, 15–17, 24, 25 we considered hospice enrollment (after initial 
consult) to be within the treatment pathway.
Study Outcomes—Using Medicare claims, we identified hospitalizations in the last 7, 30 
or 60 days of life, and ER visits (without subsequent hospitalizations) in the last 30 or 60 
days of life. We also identified the occurrence of any potentially burdensome end-of-life care 
transition since higher rates of such transitions have been shown to be associated with 
markers of poor quality NH care.14 A potentially burdensome care transition was defined as 
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hospitalizations or hospice admissions within three days of death or two or more 
hospitalizations or ER visits (without subsequent hospitalizations) in the last 30 days of life.
Although not a main outcome, we examined total Medicare Part A expenditures in post-
consult time periods: the last 7, 30 and 60 days of life. Expenditures were standardized to 
2007 dollars.
Covariates for Propensity-score Matching and Multivariate Models—Resident-
level sociodemographic variables included age, gender, marital status (married vs. other), 
and race (non-white vs. white). Per baseline MDS, preference variables included the 
presence or absence of DNR and DNH orders. Other baseline variables were diagnoses of 
cancer, dementia, both or neither, functional and cognitive impairment and whether a NH 
stay was short or long (≥90 days). Functional impairment was represented by the activities 
of daily living (ADL) scale, ranging from 0 to 28 (higher values indicating greater 
impairment). The Cognitive Performance Scale (CPS) reflected cognitive impairment, with 
scores ranging from 0 to 6 categorized as intact to mild impairment (0–2), moderate to 
moderate severe (3–4), and severe to very severe (5–6). In addition, an MDS variable 
denoting unstable, deteriorating, or declining cognitive or functional status was included as 
were variables to reflect the days between the baseline MDS and death (categorized). 
Finally, we controlled for previous acute care use, whether a resident had 1 or ≥2 
hospitalizations 90 days prior to the baseline MDS.
Using aggregated MDS data, we created continuous variables reflecting a NH’s percentage 
of non-white residents and its casemix severity, based on Medicare’s Resource Utilization 
Groups (RUGS). NH-level variables from the OSCAR database included chain affiliation, 
for-profit status, and NH employment of any nurse practitioner/physician assistant (all yes/
no), as well as the proportion of residents with Medicaid or Medicare as primary payer. A 
continuous variable represented the distance between NHs and their nearest hospitals. 
Lastly, we included indicator variables for state and for year of resident’s death.
Analyses—For each treatment group and its potential controls, we estimated a logistic 
multivariate regression model of the likelihood of a decedent having a palliative care consult. 
We then used k-nearest neighbor with caliper pscore matching with replacement to choose 
the three closest controls whose logit pscore fell within one-fifth of the standard deviation of 
the mean logit pscore for each consult recipient. This resulted in 477 consult decedents and 
1,174 controls. There were 101 consult decedents and 263 controls in the ≤7 days group; 
162 and 410 in the 8–30 days group; 84 and 212 in the 31–60 days group and 130 and 289 in 
the 61–180 days group. Covariate balance was achieved by examining standardized 
differences (see Online Supplemental Material (and Tables S2–S5) for a full description of 
the pscore matching and model statistics).26, 27
To evaluate our outcomes, we controlled for any remaining confounding28 by using 
weighted multivariate logistic regressions with the same variables used for matching. The 
weights were normalized weights generated by the pscore matching process, and the Wald 
X2 test was used to assess fit of the weighted models. To evaluate Medicare expenditures 
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given the skewed nature of such data, we used generalized linear modeling with gamma 
distribution and a log link function in Stata.
RESULTS
Within the 46 study NHs, 10% of the 6,458 residents who died between 2006 and 2010 had 
initial palliative care consults in the last 180 days of life. Decedents who had consults were 
very different from unmatched decedents without consults (see Tables 1 and 2). However, 
after pscore matching no statistically significant differences remained and mean 
standardized differences between residents with and without consults post matching ranged 
from 3.4 to 5.6, compared to 16.9 to 24.7 prior to matching (see On-Line Supplemental 
Material, Tables S2–S5).
Overall, 39% of the (weighted) study population was male and 5% were non-white. At 
baseline, 14% had severe cognitive impairment and the average ADL score was 19 (with 28 
representing total impairment). Also at baseline, 69% of the study population had DNR and 
8% had DNH orders. Last, 55% were in NHs in North Carolina and 46% in RI NHs (data 
not shown).
As shown in Table 3, across all treatment groups and for all outcomes, residents with 
consults compared to matched controls had markedly lower adjusted rates of end-of-life 
hospitalizations. Furthermore, earlier admission to consult programs was associated with 
lower hospitalization rates (Table 3). Residents with the earliest consult exposure (61–180 
days) had adjusted hospitalization rates in the last 7 and 30 days of life of 6.9% (95% CI, 
5.47 to 8.37) and 15.4% (95% CI, 12.58 to 18.19), respectively; this compares to adjusted 
rates in the last 7 and 30 days of life of 13.1% (95% CI, 10.45 to 15.74) and 22.6% (95% CI, 
18.61 to 26.63), respectively for decedents with consults 31–60 days before death (Table 3).
The likelihood of having an ER visit in the last 30 and 60 days of life was lower for residents 
with palliative care consults in both the 31–60 and 61–180 day consult groups. However, the 
difference was only statistically significant for NH residents in the 31–60 day consult group 
(Table 3). Residents with initial consults 61–180 days before death had almost half the 
adjusted rate of potentially burdensome transitions as did matched controls and this 
difference was statistically significant (Table 3).
The adjusted mean total Medicare expenditures after palliative care consult start dates were 
similar for those with versus without palliative care consults (Table 4). However, compared 
to controls, expenditures in the last 7 days of life were significantly lower for residents with 
initial consults in the last 30 and 61–180 days of life. Of interest and for residents with 
consults and their matched controls, Medicare hospice expenditures in the last 7 and 30 days 
of life increased as initial consults were further from death (see On-Line Supplemental 
Material, Table S6).
DISCUSSION
This study provides the first empirical evidence of the value of palliative care consults 
provided in NHs. It shows a robust association between NH residents’ receipt of consults 
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and lower rates of end-of-life acute care use and potentially burdensome care transitions. 
Also, rates were generally lower with earlier consults and lowest when initial consults were 
61–180 days before death. Residents’ with consults had adjusted end-of-life hospitalization 
rates 4 to 16 absolute percentage points lower than matched controls; and, when initial 
consults began 61–180 days before death the rate of potentially burdensome transitions was 
12 absolute percentage points lower for residents with consults compared to controls. 
Additionally, evaluation of Medicare expenditures showed no additional cost appeared to be 
associated with NH palliative care consults. Thus, this research suggests specialty palliative 
care consults add value to NH care for residents with advanced illness.
Study findings are in agreement with previous studies of palliative care consults in other 
settings,12,15,24 and with studies showing earlier timing of hospice or palliative care has 
greater effects on end-of-life outcomes.13,15,16,18,19 They are also in agreement with a study 
from a single NH in which receipt of palliative care consults was associated with lower ER 
use.29
Specialty palliative care consults are likely to facilitate reductions in acute care use and 
potentially burdensome care transitions through two primary mechanisms. First, they likely 
provide (earlier) palliative care exposure and symptom management for those who either do 
not desire or do not qualify for Medicare hospice, such as residents receiving Medicare Part 
A SNF care. Second, they facilitate and begin (earlier) conversations about prognoses and 
person-centered care preferences.24 Such conversations often do not occur in NHs.30 
Alternatively, consult referral could be a signal of a desire to change goals of care to focus 
on quality of life or reflect recognition by clinicians that current care is non-beneficial.
It is well known is that NH residents with hospice, compared to those without, have lower 
end-of-life acute care use;18,20 nonetheless, they incur greater Medicare expenditures in their 
last year of life, primarily because of long hospice stays.7,9 This study provides evidence of 
an approach that could potentially lead to timelier hospice enrollment by improving 
specialty palliative care access to persons in NHs with advanced serious illness. However, 
this approach is not financially feasible for most palliative care provider organizations (often 
subsidiaries of hospices) since Medicare Part B visit payments are reported to inadequately 
cover the personnel and administrative costs associated with specialty palliative care 
consults.3,6,10 Hospital-based palliative care programs receive the same Medicare Part B 
payment but nearly always offset the uncovered costs through savings resulting from 
reductions in the intensity of care.
Study findings support further consideration and study of the benefits and costs of an 
enhanced Medicare Part B visit payment for specialty palliative care consults in NHs. As in 
our study NHs, specialty palliative care consults could primarily be provided by nurse 
practitioners or physician assistants with palliative care expertise under the supervision of a 
physician with palliative care training and certification.31 This consult policy would ensure 
providers have an adequate level of palliative care proficiency while also resulting in greater 
availability of specialty palliative care expertise in NHs.5,6 While the shortage of palliative 
care physician specialists is a concern,32 there is a cadre of hospice providers capable of 
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providing these specialty consults and they may be incentivized to do so if higher payment 
for specialty palliative care visits were available.
While we did not observe Medicare savings with consults (except in the last seven days of 
life), accountable care organizations may find cost savings to be present when fee for service 
incentives are eliminated for Medicare SNF care. Thus, similar to the myriad of studies 
showing hospital cost savings when patients receive palliative care consults,15–17,24,25 
savings may be experienced by providers accountable for care across settings. With the 
advent of NH readmission penalties and as CMS begins its bundled care initiative and tests 
an acute care hospital and (90-day) post-acute care episode bundled payment, NHs much 
like hospitals may find it financially beneficial to consider provision of specialty palliative 
care consults to seriously ill residents.
A major strength of this study is our use of rigorous methods. Pscore matching and analysis 
were by strata representing the time between initial consult and death. Matching corrected 
substantially for imbalance between residents with and without consults, and any residual 
confounding was controlled for in multivariate analyses. However, in addition to the 
observational nature of this study, we are unable to comment on the decision-making around 
consult referral and on factors associated with referral other than those represented in our 
secondary data sources. Also, this research had a retrospective cohort design and important 
concerns about bias with the use of a retrospective study design have been noted.33 By use 
of pscore matching and examination of outcomes only in the last 60 days of life, we have 
attempted to minimize this bias. Additionally, findings are not necessarily nationally 
generalizable given they focus on NHs in only two states. Still, mean and median rates of 
hospital death and hospitalization in the last six months of life in North Carolina and Rhode 
Island are similar to national rates.34 Furthermore, while research across additional states is 
desirable, the lack of dedicated palliative care payment or CPT codes make widespread 
study clearly challenging. This study focused on evaluating the receipt of any PC consult 
and we did not have data on “the dose” of palliative care (i.e., number of visits). However, as 
discussed in Methods, at both study sites, initial consult visits are quite similar and included 
goals of care discussions. Finally, given data limitations, we did not evaluate and thus cannot 
comment on the value of consults beginning more than six months prior to death.
In conclusion, specialty palliative care consults, especially those done earlier in the disease 
trajectory, appear to offer a value-added approach to decreasing potentially burdensome end-
of-life transitions and acute care use for NH residents. Findings suggest Medicare and 
provider policy supporting concurrent specialty palliative care consults in NHs may lead to 
reductions in costly and often unsettling and discretionary hospital use - use that is likely to 
undermine residents’ quality of life. Further study of this model using practical clinical trials 
is recommended.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 3
Adjusted Ratesa of Acute Care Use: Residents with Palliative Care in Differing Time Periods and Their 
Matched Controls
Outcomes With PC Consult
Adjusted Rate, (95% CI)
Without PC Consult
Adjusted Rate, (95% CI)
P-value
Hospitalization in last 7 days of life
 Days between death and initial PC visit
 ≤ 7 daysb 20.8 (16.93 to 24.65) 36.0 (32.97 to 38.97) .008
 8–30 days 11.1 (9.79 to 12.43) 22.0 (20.62 to 23.41) .002
 31–60 daysc 13.1 (10.45 to 15.74) 21.4 (18.81 to 24.05) .138d
 61–180 days 6.9 (5.47 to 8.37) 22.9 (20.48 to 25.42) <.001
Hospitalization in last 30 days of life
 Days between death and initial PC visit
 31–60 days 22.6 (18.61 to 26.63) 32.9 (30.15 to 35.72) .069
 61–180 days 15.4 (12.58 to 18.19) 30.6 (27.80 to 33.49) <.001
Hospitalization in last 60 days
 Days between death and initial PC visit
 61–180 days 26.9 (22.99 to 30.86) 40.1 (36.98 to 43.28) .003
ER visits in last 30 days of life
 Days between death and initial PC visit
 31–60 days 8.3 (5.45 to 11.21) 15.9 (13.39 to 18.36) .023
 61–180 dayse,f 10.8 (8.50 to 13.03) 14.4 (12.51 to 16.21) .504
ER visits in last 60 days of life
 Days between death and initial PC visit
 61–180 daysf 16.2 (13.45 to 18.86) 20.3 (18.27 to 22.24) .265
Burdensome Transitions
 Days between death and initial PC visit
 ≤ 7 daysb 41.6 (36.47 to 46.69) 41.6 (38.10 to 45.07) .995
 8–30 days 28.4 (25.77 to 31.02) 25.9 (24.32 to 27.54) .638
 31–60 daysg 22.6 (19.41 to 25.82) 26.6 (24.40 to 28.78) .275
 61–180 days 16.2 (13.74 to 18.57) 28.2 (25.82 to 30.59) .004
Abbreviations: PC, palliative care; ER, emergency room
aAdjusted rates based on multivariate models controlling for the following variables, unless otherwise noted: For Residents: at baseline, age, 
marital status, non-White, do-not-resuscitate order, do-not-hospitalize order, 4-category dementia/cancer diagnoses, activities of daily living 
impairment, cognitive impairment, stability of cognition and functioning; days between baseline assessment and death; 1 or 2 or more 
hospitalizations in the 90 days prior to baseline assessment and year of death. For nursing homes: percent non-White, resident casemix, chain 
affiliation, profit status, employment of any nurse practitioner and/or physician assistant, proportion of residents on Medicare or Medicaid as 
primary payer, distance between nursing home and nearest hospital; and, location of nursing home (Rhode Island or North Carolina).
b
Models did not include non-White, percent non-White, and 2 or more hospitalizations in 90 days prior to baseline assessment.
c
Do-not-resuscitate order was removed from the model because it predicted the outcome perfectly.
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d
P-values do not perfectly coincide with 95% CI because p-values were generated from the predicted probabilities while the p-value was taken 
from the palliative consult estimate of the multivariate model.
eCognitive impairment was removed from the model because it predicted the outcome perfectly.
f
The 4-category dementia/cancer variable was removed from the model because it predicted the outcome perfectly. Dichotomous measures of 
dementia and cancer were added.
g
To achieve model fit, this model did not include non-White, percent non-White, profit status, or presence of a Do-Not-Resuscitate order. It also 
replaced the 4-category dementia/cancer variable with dichotomous measure of dementia and cancer; collapsed categories of time from baseline 
assessment to death, year of death, and cognitive status; and added a quadratic term for distance from nursing home to the nearest hospital.
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Table 4
Adjusted Medicare Expenditures: Residents with Palliative Care (PC) in Differing Time Periods and Their 
Matched Controlsa,b
Outcomes With PC Consult
Adjusted Expenditures, (95% CI)
Without PC Consult
Adjusted Expenditures, (95% CI)
P-value
Expenditures in last 7 days of life
 Days between death and initial PC visit
 ≤ 7 daysc 6365 (5997 to 6734) 9243 (8708 to 9778) <.001
 8–30 days 4414 (4249 to 4579) 5028 (4841 to 5216)
.117d
 31–60 days 4662 (4395 to 4929) 5042 (4754 to 5331) .525
 61–180 days 3097 (2926 to 3267) 4140 (3912 to 4367) .008
Expenditures in last 30 days of life
 Days between death and initial PC visit
 31–60 days 9784 (9241 to 10327) 9012 (8512 to 9511) .416
 61–180 days 7000 (6609 to 7390) 7000 (6610 to 7390) 1.000
Expenditures in last 60 days of life
 Days between death and initial PC visit
 61–180 days 12151 (11443 to 12858) 11496 (10827 to 12166) .528
Abbreviations: PC, palliative care
aAdjusted rates based on multivariate models controlling for the following variables, unless otherwise noted: For Residents: at baseline, age, 
marital status, non-White, do-not-resuscitate order, do-not-hospitalize order, 4-category dementia/cancer diagnoses, activities of daily living 
impairment, cognitive impairment, stability of cognition and functioning; days between baseline assessment and death; 1 or 2 or more 
hospitalizations in the 90 days prior to baseline assessment and year of death. For nursing homes: percent non-White, resident casemix, chain 
affiliation, profit status, employment of any nurse practitioner and/or physician assistant, proportion of residents on Medicare or Medicaid as 
primary payer, distance between nursing home and nearest hospital; and, location of nursing home (Rhode Island or North Carolina).
bValues represent US dollars standardized to 2007 values.
c
Models did not include non-White, percent non-White, and 2 or more hospitalizations in 90 days prior to baseline assessment.
d
P-values do not perfectly coincide with 95% CI because p-values were generated from the predicted probabilities while the p-value was taken 
from the palliative consult estimate of the multivariate model.
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